Researchers predict nearly 1.3 million cancer deaths in Euro... ( world standardised death rates from lun...)

Researchers predict nearly 1.3 million cancer deaths in Europe in 2011

Date:2/8/2011

, world standardised death rates from lung cancer in women have gone up from 12.55 per 100,000 of the female population in 2007 to 13.12 in 2011. Lung cancer has overtaken breast cancer as the first cause of cancer death in Polish women, as well as in women from the UK. The number of women who will die from lung cancer this year in the UK is 15,632 (compared to 14,900 in 2007); this represents a slight drop in the death rate from 20.57 per 100,000 women in 2007 to 20.33 in 2011. In Poland, 6,343 women will die from lung cancer this year compared to 5,643 in 2007, and this represents an increase in the death rate from 15.53 per 100,000 women to 16.60 in 2011.

The overall downward trend in cancer death rates is driven mainly by falls in breast cancer mortality in women, and lung and colorectal cancer in men. "Lung, colorectal and breast cancers are the top causes of cancer deaths, and these are showing major changes," said Prof La Vecchia.

Declines in mortality from other major cancers such as stomach, uterus, prostate and leukaemia are likely to be seen in 2011, say the researchers. A worrying increase in deaths from pancreatic cancer in women, which had been observed in 2004, appears to have levelled off.

"Pancreatic cancer mortality is favourably influenced by the decline in smoking in men, but unfavourably influenced by the increased prevalence of obesity and diabetes," said Prof La Vecchia.

In their study the authors write: "A substantial decline in total cancer mortality rates has been observed since the late 1980s in men and since even earlier in women in the EU. Between 1990-94 and 2000-04 the rates declined by 9% in men. and by 8% in women.In men the decline has continued in 2007 and will likely carry on up to 2011, and the greatest drop is predicted in Germany. For women too, the declines persist, but the trend in Polish women is less favourable. Given that Poland has the highest total cancer mortality rates in both sexes,
'/>"/>

Contact: Emma Mason
wordmason@mac.com
European Society for Medical Oncology
Source:Eurekalert

1

GOOD

Page: 1 2 3
Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor

Post Your Comments:

(Date:5/24/2013)... Mirena IUD lawyers at the Rottenstein Law Group are ... than 59,229 complaints since 2004 from women claiming they suffered ... as the Mirena IUD.* , Among the most common of ... where the IUD came out on its own. There are ... article. “Abdominal pain is also common, with 3,774 complaints. And ...

(Date:5/24/2013)... 24, 2013 Gift Card Network ... competitors in sustainable card material, are combining forces ... materials as a sustainable gift card substrate. , ... industry challenges and increase education and usage of ... support the reduction of carbon footprint and environmental ...

(Date:5/24/2013)... failed to replicate what appeared to be breakthrough results ... were published last year in the journal Science ... suggested that the drug bexarotene (marketed as Targretin) could ... a pathological hallmark of Alzheimer,s disease in ... the 2012 report, drug treatment quickly removed most of ...

(Date:5/24/2013)... Los Angeles, CA (PRWEB) May 24, 2013 ... is to present the 3rd Annual EB-5 Investment Summit: ... 2013. The Dealmakers Conference will focus on exploring alternative ... provide the latest market, legal and economic information, and ... legal professionals within the EB-5 industry. , "Our ...

(Date:5/24/2013)... 24, 2013 Mike Stoler believes that ... successful business people in New York. That’s why ... weekly on CUNY TV. And that’s why he ... Allergy Associates, LLP (ENTA)—the largest single specialty practice in ... throat, allergy and audiology specialists and sub-specialists service communities ...

Breaking Medicine News(10 mins):Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2 Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2 Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3 Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2 Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3 Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2 Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2 Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3 Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4

[0] Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes [0] Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants [0] Multiple research teams unable to confirm high-profile Alzheimer's study [0] Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California [0] Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York

... self esteem, SAUSALITO, Calif., May 14 When Peggy ... afraid to go to school,because she had lost her hair ... of her custom-made hair pieces and invited her and her,mother ... -- and raised the money to pay for it., ...

... Room Temperature Stable Treatment for Hemophilia With ... Convenience to Patients, PRINCETON, N.J., May 13 ... and Drug Administration (FDA) has approved,NovoSeven(R) RT (Coagulation ... temperature stable recombinant product available,for the treatment of ...

... the unmet needs of ... and communities, SACRAMENTO, Calif., May 13 The ... for the use of,traditional and technologically advanced forms of ... nonprofit charities. Founding,organizations for this new alliance include Disabled ...

... Promoting ... Healthy Workplace, ... Health, a national non-profit organization of large employers, today,honored Data ... healthy workplace and encouraging a healthy,lifestyle for its employees and ...

... demonstrating ... time since separation; strategic investments ... - Management updates financial guidance based on year to date performance ... and operational momentum, BATESVILLE, Ind., May 13 Hill-Rom Holdings,Inc. (NYSE: HRC ), reporting for ...

... - Third quarter fiscal 2008 revenue of $21.9 million versus $23.8 million ... in the same quarter last year. ... ... Natural,Alternatives International, Inc. ("NAI") (Nasdaq: NAII ), a leading,formulator, manufacturer and ...

Teen Girl Loses Hair But Gains Support FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors Charities Form Alliance to Preserve and Improve Charity Bingo National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year Natural Alternatives International, Inc. Announces Third Quarter Results

(Date:5/23/2013)... Mass. , May 23, 2013 Haemonetics Corporation (NYSE: ... Lindop , CFO & EVP-Business Development, will present at ... Conference in Boston, MA on May ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may access ... About Haemonetics Haemonetics (NYSE: ...

(Date:5/23/2013)... MGC Diagnostics Corporation (NASDAQ: MGCD ) ... scheduled a conference call to discuss its financial results ... April 30, 2013. The call will be at 4:30 ... will report financial results for the second quarter of ... May 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO ...

(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...

Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2 Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2

[0] Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference [0] MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 [0] Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support

... Oct. 28 Octapharma Group and Fresenius Kabi ... regarding the use of Fresenius Kabi,s HESylation® Technology ... the agreement, Fresenius Kabi will license its proprietary ... based on hydroxyethyl starch ("HES") which will be ...

... , MALVERN, Pa., Oct. 28 Featuring the lowest ... Siemens Healthcare,s SOMATOM® Definition Flash dual-source computed tomography (CT) ... for Children, Orlando, Fla., to better serve its pediatric ... of the radiation dose that systems previously required to ...

Cached Medicine Technology:Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein 2 Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein 3 Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children 2 Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children 3

Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children

This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,408-9) or contact custom...

... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 1-10 Inaccuracy (%) ... Imprecision(%) ... 0.1 Dimensions: ...

... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...

This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 2-20 microliter range....

Medicine Products:

Corning Lambda Single Channel Pipettor, 0.5-10 ul Variable Volume Pipette H10 Pipetman Ultra U10 Micropipet, adjustable volume, 2-20 microliter